(HealthDay News) — Use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) is associated with the risk for retained gastric contents and inadequate bowel preparation during endoscopic procedures, ...

Brands like Kourtney Kardashian's Lemme are claiming to provide the same benefits as GLP-1 medications like Ozempic, Wegovy, ...

Ozempic and similar drugs are often effective because they produce feelings of satisfaction, in line with the NBC theory of ...

Discover tailored ADME study options that are tailored to meet specific research goals and accelerate R&D programs.

GLP-1 receptor agonists are being recommended on social media, raising questions about who can see the content and what the ...

While the food industry has never met a diet trend it didn’t seek to capitalize on, GLP-1s at one point seemed to present an ...

In real-world settings multiple factors contribute to non-persistence, including adverse effects, high cost-sharing and ...

Research shows patients taking weight-loss drugs like Ozempic and Wegovy are more likely to have food left in the stomach or ...

From biochemist to executive supplier to angel investor to company founder and CEO, Maria Maccecchini, Ph.D.’s ...

And to some people who take Ozempic or other GLP-1 medications, the lack of cravings feels like freedom. For others, life ...

I highlight potential of Biomea Fusion's diabetes drug amid competition, advises caution with stock due to risks. Read more ...